Pain Therapeutics (PTIE)

Company Overview
Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States. Its Phase III clinical trial products include Remoxy, which is an anti-abuse version of long-acting oxycodone; and Oxytrex, which is an opioid painkiller for the treatment of chronic pain. The company has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers. Pain Therapeutics was founded in 1998 and is based in South San Francisco, California.
read more

QUOTE

As of 06:20AM EDT July 28, 2014
$ 4.63   -0.22 (-4.54%)
Today's Open: 4.8 Previous Close: 4.85
Today's High: 4.86 Volume: 218,137
Today's Low: 4.55 Avg Vol: 229,361
52 Week High: 6.11 Bid (size): 100
52 Week Low: 2.16 Ask (size): 1,400

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 7801 N Capital of Texas Highway, Suite 260, Austin, TX 78731, United States
Mailing Address: -
Phone: 512-501-2444
Fax: 512-614-0414
Website: http//www.paintrials.com

Company Details:

Symbol: PTIE
SIC: 2834
State location: CA
Sector: -
State of Inc: DE
Employees: 27
Type: -

Key executives:

Name Age Position
Grant L. Schoenhard Ph.D. 69 Chief Scientific Officer
Nadav Friedmann M.D. 71 Chief Operating Officer, Chief Medical Officer
Peter S. Roddy 54 Chief Financial Officer, Principal Accounting Officer and VP
Remi Barbier 54 Founder, Chairman, Chief Exec. Officer and Pres

LATEST ARTICLES

LATEST STOCK PROMOTIONS

Pain Therapeutics, Inc (PTIE) MESSAGE BOARD

Post # Subject Re Name Date
1 The latest news of the company are... 0
2 Here on this message board we are inviting... 0